Whole exome sequencing of suspected mitochondrial patients in clinical practice

Mitochondrial disorders are characterized by a broad clinical spectrum. Identical clinical signs and symptoms can be caused by mutations in different mitochondrial or nuclear genes. Vice versa, the same mutation can lead to different phenotypes. Genetic syndromes and neuromuscular disorders mimicking mitochondrial disorders further complicate the diagnostic process. Whole exome sequencing (WES) is the state of the art next generation sequencing technique to identify genetic defects in mitochondrial disorders. Until recently it has mainly been used as a research tool. In this study, the use of WES in routine diagnostics is described. The WES data of 109 patients, referred under the suspicion of a mitochondrial disorder, were examined in two steps. First, the data were filtered using a virtual gene panel of genes known to be associated with mitochondrial disease. If negative, the entire exome was examined. A molecular diagnosis was achieved in 39 % of the heterogeneous cohort, and in 57 % of the subgroup of 42 patients with the highest suspicion for a mitochondrial disease. In addition to mutations in genes known to be associated with mitochondrial disorders (e.g. TUFM, MTFMT, FBXL4), in the subgroup of patients with the lowest suspicion for a mitochondrial disorder we found mutations in several genes associated with neuromuscular disorders (e.g. SEPN1, ACTA1) and genetic syndrome (e.g. SETBP1, ARID1B). Our results show that WES technology has been successfully implemented as a state-of-the-art, molecular diagnostic test for mitochondrial disorders as well as for the mimicking disorders in daily clinical practice. It also illustrates that clinical and biochemical phenotyping is essential for successful application of WES to diagnose individual patients.

[1]  T. Meitinger,et al.  Cellular rescue-assay aids verification of causative DNA-variants in mitochondrial complex I deficiency. , 2011, Molecular genetics and metabolism.

[2]  A. Rötig,et al.  Secondary Mitochondrial Respiratory Chain Defect Can Delay Accurate PFIC2 Diagnosis. , 2014, JIMD reports.

[3]  M. Fichera,et al.  TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion , 2014, American journal of medical genetics. Part A.

[4]  J. Smeitink,et al.  Mitochondrial Translation and Beyond: Processes Implicated in Combined Oxidative Phosphorylation Deficiencies , 2010, Journal of biomedicine & biotechnology.

[5]  C. Katsetos,et al.  Mitochondrial dysfunction in neuromuscular disorders. , 2013, Seminars in pediatric neurology.

[6]  Christian Gilissen,et al.  A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.

[7]  Robert W. Taylor,et al.  Defective i6A37 Modification of Mitochondrial and Cytosolic tRNAs Results from Pathogenic Mutations in TRIT1 and Its Substrate tRNA , 2014, PLoS genetics.

[8]  Christian Gilissen,et al.  Disease gene identification strategies for exome sequencing , 2012, European Journal of Human Genetics.

[9]  E. Leshinsky‐Silver,et al.  Diagnosis by whole exome sequencing of atypical infantile onset Alexander disease masquerading as a mitochondrial disorder. , 2014, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[10]  D. Valenti,et al.  Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: An overview of Down syndrome, autism, Fragile X and Rett syndrome , 2014, Neuroscience & Biobehavioral Reviews.

[11]  V. Beneš,et al.  Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy , 2011, Human mutation.

[12]  Rutger O. Vogel,et al.  Assembly factors as a new class of disease genes for mitochondrial complex I deficiency: cause, pathology and treatment options. , 2012, Brain : a journal of neurology.

[13]  Christian Gilissen,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, New England Journal of Medicine.

[14]  V. Mootha,et al.  Targeted exome sequencing of suspected mitochondrial disorders , 2013, Neurology.

[15]  Y. Okazaki,et al.  Diagnosis and molecular basis of mitochondrial respiratory chain disorders: exome sequencing for disease gene identification. , 2014, Biochimica et biophysica acta.

[16]  J. Penn,et al.  Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity , 2013, BMC Medical Genetics.

[17]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[18]  R. Rodenburg,et al.  Mitochondrial Energy Production Correlates With the Age-Related BMI , 2009, Pediatric Research.

[19]  M. Huynen,et al.  A mutation in C2orf64 causes impaired cytochrome c oxidase assembly and mitochondrial cardiomyopathy. , 2011, American journal of human genetics.

[20]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[21]  K. Pollard,et al.  Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.

[22]  V. Mootha,et al.  Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease , 2012, BMC Medical Genetics.

[23]  A. Zharkikh,et al.  Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.

[24]  A. Hoischen,et al.  A complex V ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy. , 2013, Brain : a journal of neurology.

[25]  S. Carr,et al.  A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.

[26]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[27]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[28]  Beril Talim,et al.  Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. , 2014, JAMA.

[29]  B. Meyer,et al.  Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic/myopathic syndrome , 2014, Neuromuscular Disorders.

[30]  D. Jaffe,et al.  Molecular Diagnosis of Infantile Mitochondrial Disease with Targeted Next-Generation Sequencing , 2012, Science Translational Medicine.

[31]  L. Vissers,et al.  Genome sequencing identifies major causes of severe intellectual disability , 2014, Nature.

[32]  Werner J H Koopman,et al.  Monogenic mitochondrial disorders. , 2012, The New England journal of medicine.

[33]  J. Veltman,et al.  Genome and exome sequencing in the clinic: unbiased genomic approaches with a high diagnostic yield. , 2012, Pharmacogenomics.

[34]  R. Rodenburg,et al.  Mitochondrial disease criteria , 2006, Neurology.

[35]  A. Suomalainen,et al.  Next‐generation sequencing for mitochondrial disorders , 2014, British journal of pharmacology.

[36]  Marni J. Falk,et al.  Molecular Genetic Testing for Mitochondrial Disease: From One Generation to the Next , 2012, Neurotherapeutics.

[37]  T. Wieland,et al.  Phenotypic spectrum of eleven patients and five novel MTFMT mutations identified by exome sequencing and candidate gene screening. , 2014, Molecular genetics and metabolism.

[38]  M. Pineda,et al.  Congenital disorders of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[39]  Xiaonan H. Wang,et al.  Understanding mitochondrial complex I assembly in health and disease. , 2012, Biochimica et biophysica acta.